Cargando…
Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects
Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a cytokine storm and acute respiratory distress syndrome, the leading cause of COVID-19-related mortality and morbidity. So far, no th...
Autores principales: | Abdelgawad, Mai, Bakry, Nourhan Saied, Farghali, Ahmed A., Abdel-Latif, Ahmed, Lotfy, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379570/ https://www.ncbi.nlm.nih.gov/pubmed/34419143 http://dx.doi.org/10.1186/s13287-021-02542-z |
Ejemplares similares
-
Mesenchymal stromal cells coated with anti-ACE2 antibodies might improve efficacy against COVID-19
por: Bakry, Nourhan Saied, et al.
Publicado: (2021) -
Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials
por: Lotfy, Ahmed, et al.
Publicado: (2023) -
Current Trends and Future Perspective of Mesenchymal Stem Cells and Exosomes in Corneal Diseases
por: Mansoor, Hassan, et al.
Publicado: (2019) -
Human mesenchymal stem cells - current trends and future prospective
por: Ullah, Imran, et al.
Publicado: (2015) -
Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective
por: Gupta, Ashim, et al.
Publicado: (2020)